farnesol has been researched along with tetradecanoylphorbol acetate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badwey, JA; Ding, J; Gilbert, BA; Lim, YH; Rando, RR | 1 |
Kanayama, Y; Negoro, N; Okamura, M; Takeda, T; Umetani, N | 1 |
Bychkov, R; Chapman, J; Haller, H; Luft, FC; Luft, UC; McCarron, DA; Roullet, CM; Roullet, JB; Xue, H | 1 |
Arpaia, M; Banfi, C; Mussoni, L; Sironi, L; Tremoli, E | 1 |
Alam, MS; Athar, M; Chaudhary, SC; Siddiqui, MS | 1 |
5 other study(ies) available for farnesol and tetradecanoylphorbol acetate
Article | Year |
---|---|
Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C.
Topics: Animals; Diglycerides; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Farnesol; Guinea Pigs; In Vitro Techniques; Kinetics; Models, Molecular; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphates; Phosphoproteins; Protein Kinase C; Superoxides; Tetradecanoylphorbol Acetate; Triazoles | 1995 |
Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages.
Topics: Cell Line; Dactinomycin; Enzyme Inhibitors; Farnesol; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Macrophages; Membrane Proteins; Mevalonic Acid; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; RNA, Messenger; Scavenger Receptors, Class B; Tetradecanoylphorbol Acetate | 1996 |
Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells.
Topics: Animals; Arteries; Calcium; Calcium Channel Blockers; Cells, Cultured; Drug Interactions; Farnesol; In Vitro Techniques; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Rats; Signal Transduction; Tetradecanoylphorbol Acetate; Thapsigargin | 1997 |
Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
Topics: Cells, Cultured; Depression, Chemical; Diterpenes; Endothelium, Vascular; Farnesol; Fatty Acids, Monounsaturated; Fluvastatin; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipopolysaccharides; Mevalonic Acid; Plasminogen Activator Inhibitor 1; RNA, Messenger; Tetradecanoylphorbol Acetate; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha; Umbilical Veins | 2000 |
Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Apoptosis; Chemoprevention; Cyclooxygenase 2; Disease Models, Animal; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Farnesol; Inflammation; Mice; Ornithine Decarboxylase; Oxidative Stress; ras Proteins; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2009 |